Abstract Topics

Abstract Topics

View abstract topics below and start preparing your abstract. Grab the opportunity to present on a fantastic international platform!

  • Cytomorphology
  • Flow cytometry
  • Molecular aberrations (cytogenetic, genetic, gene expression)
  • Cost of care
  • Patient-reported outcomes
  • Efficacy outcome measures
  • Normal, MDS, and leukemic stem cells
  • Clonal diversity & evolution
  • MDS Mouse models (GEMMS, PDX)
  • Somatic mutations
  • Spliceosome machinery
  • Gene expression profiling
  • Epigenetic deregulation
  • Immune deregulation
  • Microenvironment and stem cell niche
  • Prognostic factors of outcome and risk assessment
  • Predictive factors of response to treatment
  • MDS in childhood
  • Hereditary MDS including predisposition syndromes
  • MDS with ring sideroblasts
  • Chronic myelomonocytic leukemia and overlap syndromes (MDS/MPN)
  • MDS with deletion 5q
  • Treatment-related MDS

Current treatment options

  • Hypomethylating agents
  • Lenalidomide
  • Hematopoietic growth factors
  • Immunosuppressive therapy

New developments

  • Preclinical studies
  • Phase I studies

Clinical trials

  • Phase II-III

Allogeneic hematopoietic cell transplantation

  • Bridging to transplantation
  • Post-transplantation treatment

Supportive care

  • Iron overload
  • Transfusion medicine and MDS
  • Geriatric issues and MDS

Quality of life